| Literature DB >> 27172303 |
Megan D Brinkworth1, Mouhammad Aouthmany, Michael Sheehan.
Abstract
Within the last 50 years, the pharmacologic market for gastric disease has grown exponentially. Currently, medical management with histamine 2 receptor antagonist and proton pump inhibitors are the mainstay of therapy over surgical intervention. These are generally regarded as safe medications, but there are growing numbers of cases documenting adverse effects, especially those manifesting in the skin. Here we review the pharmacology, common clinical applications, and adverse reactions of both histamine 2 receptor antagonists and proton pump inhibitors with a particular focus on the potential for allergic reactions including allergic contact dermatitis.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27172303 DOI: 10.1097/DER.0000000000000172
Source DB: PubMed Journal: Dermatitis ISSN: 1710-3568 Impact factor: 4.845